| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.03 | $40.32 (0%) | 🛒 Add to cart |
| 20 | $3.02 | $80.65 $60.48 (25%) | 🛒 Add to cart |
| 30 | $2.35 | $120.97 $70.57 (42%) | 🛒 Add to cart |
| 60 | $1.34 | $241.94 $80.65 (67%) | 🛒 Add to cart |
| 90 | $1.01 | $362.91 $90.73 (75%) | 🛒 Add to cart |
| 120 | $0.84 | $483.88 $100.81 (79%) | 🛒 Add to cart |
| 180 | $0.76 | $725.82 $136.09 (81%) | 🛒 Add to cart |
| 270 | $0.67 | $1088.72 $181.45 (83%) | 🛒 Add to cart |
| 360 | $0.59
Best per pill | $1451.63 $211.70 (85%) | 🛒 Add to cart |
Similar products
More info:
zyban
Zyban, known generically as bupropion hydrochloride, is a prescription medication that was originally developed and approved as an antidepressant (Wellbutrin) but found significant secondary use as a smoking cessation aid. It functions as a norepinephrine-dopamine reuptake inhibitor (NDRI), which is quite different from the nicotine replacement therapies like patches or gums that most people are familiar with. The story of how an antidepressant became a frontline weapon against tobacco addiction is a fascinating one in pharmacology, a classic case of serendipitous discovery.
bupropion
Bupropion is an atypical antidepressant belonging to the aminoketone class, structurally distinct from SSRIs and TCAs. It functions primarily as a norepinephrine-dopamine reuptake inhibitor with minimal serotonergic activity, which explains its unique clinical profile. We’ve been using it since the 1980s, but honestly didn’t fully appreciate its mechanisms until the late 90s. Key Components and Bioavailability Bupropion The molecular structure (β-keto-amphetamine) gives it that stimulant-like effect without actual amphetamine properties. We use three main formulations: immediate-release (IR), sustained-release (SR), and extended-release (XL).
Champix: Evidence-Based Smoking Cessation Through Neurological Modulation
Let me walk you through our experience with Champix – or varenicline, as we know it in clinical practice. When it first hit our formulary back in 2007, we were skeptical. Another smoking cessation aid? Really? But the partial agonist mechanism targeting α4β2 nicotinic acetylcholine receptors was genuinely novel – not just replacing nicotine like patches or gum, but actually blocking the reinforcing effects while reducing withdrawal. The development team at Pfizer had stumbled onto something interesting while investigating cytisine derivatives.
wellbutrin
Bupropion hydrochloride, marketed under the brand name Wellbutrin, represents a unique class of antidepressant medication that diverges significantly from traditional selective serotonin reuptake inhibitors. As an aminoketone and norepinephrine-dopamine reuptake inhibitor (NDRI), its mechanism targets different neurotransmitter systems, offering an alternative for patients who haven’t responded to or can’t tolerate SSRIs. The development journey wasn’t straightforward - our team initially struggled with the seizure risk profile during early clinical trials, requiring careful dose titration protocols that nearly derailed the entire project.
wellbutrin sr
Let me walk you through what we’ve learned about bupropion SR over the years - not from the package insert, but from actually using it day in and day out with real patients. When GlaxoSmithKline first introduced this sustained-release formulation back in the 90s, we were all skeptical about whether the delivery system would actually make a clinical difference. The immediate-release version required TID dosing that patients constantly forgot, leading to those rollercoaster plasma levels that probably contributed to the seizure risk we saw in early studies.
Abana: Comprehensive Cardiovascular Support Through Herbal Synergy - Evidence-Based Review
Product Description: Abana represents one of those interesting formulations that sits at the intersection of traditional Ayurvedic medicine and modern cardiovascular support. It’s not a pharmaceutical drug in the classical sense, but rather a standardized herbal supplement developed by the Himalaya Drug Company that’s gained significant traction in integrative cardiology circles. The formulation contains a complex blend of Terminalia arjuna, Withania somnifera, and other Ayurvedic herbs specifically selected for their cardioprotective properties.
Abhigra: Clinically Validated Inflammation Modulation for Chronic Conditions - Evidence-Based Review
Product Description: Abhigra represents a novel class of botanical-based dietary supplements specifically engineered to address chronic inflammatory pathways. Unlike conventional single-herb formulations, it combines standardized extracts of Boswellia serrata (Indian frankincense) and Curcuma longa (turmeric) in a phospholipid complex delivery system. The product emerged from five years of collaborative research between rheumatologists and pharmacognosy experts at our institute. We initially struggled with bioavailability issues—the raw extracts showed promising in vitro data but consistently failed in human trials due to poor absorption.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike earlier antipsychotics that primarily targeted dopamine D2 receptors, this atypical antipsychotic functions as a partial dopamine agonist with additional serotonin receptor activity. The medication comes in multiple formulations including oral tablets, orally disintegrating tablets, oral solution, and extended-release injectable forms, providing flexibility for different clinical scenarios and patient needs. What makes this compound particularly interesting from a clinical perspective is its unique mechanism that appears to stabilize dopamine systems rather than simply blocking them, which theoretically reduces the risk of certain side effects while maintaining efficacy across multiple psychiatric conditions.
Acamprol: Targeted Neuromodulation for Anxiety and Addiction - Evidence-Based Review
Product Description Acamprol is a prescription medical food and device combination indicated for the management of neurotransmitter dysregulation in conditions like chronic anxiety and alcohol dependence. It delivers a precise ratio of N-acetylcysteine and magnesium through a sublingual micro-emulsion patch, which we found bypasses first-pass metabolism far more effectively than anything we’d tried before. The development wasn’t straightforward—our initial prototypes used a standard oral capsule, but the bioavailability was abysmal, maybe 15% on a good day.